Insider · CIK 0001794362
Nick B. Tressler
Files at VTGN (Vistagen Therapeutics, Inc.). First filing -, latest -.
In brief
Nick B. Tressler files SEC Form 4 as CFO at VTGN (Vistagen Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Nick B. Tressler has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | VTGN Vistagen Therapeutics, Inc. | AGrant or award Common Stock | +11,712 | $0.19 | $2,250 | 11,712 | Jul 2, 2026 |
| Apr 7, 2026 | VTGN Vistagen Therapeutics, Inc. | AGrant or award Incentive Stock Option (right to buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Apr 9, 2026 |
| Dec 1, 2025 | VTGN Vistagen Therapeutics, Inc. | AGrant or award Common Stock (Right to Buy)derivative | +150,000 | - | - | 150,000 | Dec 4, 2025 |
Questions about Nick B. Tressler
Answered from the filings on this page, as of the latest one.
Is Nick B. Tressler buying or selling?
Nick B. Tressler has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Nick B. Tressler's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nick B. Tressler has 0.
Where does Nick B. Tressler file Form 4?
Nick B. Tressler has filed Form 4 at VTGN (Vistagen Therapeutics, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.